| Common Name | avoid in children under 12 |
| Scientific Name | |
| Disease Type | Contraindication |
| Host Type | human; human |
| ICD Code | |
| Distribution |
| Causative Agent | |
| Transmission |
| Symptoms Description | This is not a disease but a general pediatric safety warning applied to various medications, herbs, and treatments that carry risks such as Reye's syndrome, respiratory depression, hepatotoxicity, or unestablished safety profiles in young children. |
| Diagnosis |
| Conventional Treatment | Use age-appropriate alternatives; consult pediatric dosing guidelines or pharmacist for substitutes safe for children under 12. |
| Herbal Treatment | Select child-safe herbal alternatives with established gentle profiles (e.g., chamomile, fennel for digestion instead of stronger herbs); many herbal traditions advise lower doses or avoidance of potent bitters, alkaloids, or essential oils in pre-adolescents. |
| Prevention | Always check product labels, contraindications, and age restrictions before administering any medication, supplement, or botanical to children; follow guidelines from pharmacopeias, herbal safety compendiums (e.g., American Herbal Products Association), and pediatric references. |
| Prognosis | Excellent when appropriate alternatives are used; risk of adverse events is avoided by adhering to age-specific contraindications. |
| History | Pediatric contraindications evolved significantly after incidents such as the association of aspirin with Reye's syndrome in the 1970s-80s, leading to broad warnings for salicylate-containing herbs (e.g., willow, meadowsweet) and many pharmaceuticals. Regulatory bodies (FDA, EMA, TCM pharmacopeias, Ayurvedic texts) subsequently expanded age-related restrictions for numerous substances. |
| Reference | American Herbal Products Association Botanical Safety Handbook; PDR for Herbal Medicines; WHO monographs on selected medicinal plants; Standard pediatric pharmacology texts. |
| URL |
© 2026 Ve7tit. All rights reserved.